Edgewise Therapeutics, Inc. EWTX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Edgewise Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edgewise Therapeutics, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Edgewise Therapeutics, Inc.'s total equity?
- Edgewise Therapeutics, Inc. (EWTX) reported total equity of $493.2M in Q1 2026.
- How has Edgewise Therapeutics, Inc.'s total equity changed year-over-year?
- Edgewise Therapeutics, Inc.'s total equity increased by 14.8% year-over-year, from $429.72M to $493.2M.
- What is the long-term trend for Edgewise Therapeutics, Inc.'s total equity?
- Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s total equity has grown at a 73.3% compound annual growth rate (CAGR), from -$33.42M to $522.26M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.